Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonistused to treat type 2 diabetes and manage chronic weight, sold under brand names Ozempic, Rybelsus, and Wegovy. It works by mimicking the GLP-1 hormone to increase insulin secretion, slow gastric emptying, and reduce appetite. It is administered via weekly subcutaneous injections or daily oral tablets.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonistused to treat type 2 diabetes and manage chronic weight, sold under brand names Ozempic, Rybelsus, and Wegovy. It works by mimicking the GLP-1 hormone to increase insulin secretion, slow gastric emptying, and reduce appetite. It is administered via weekly subcutaneous injections or daily oral tablets.